Stifel Financial’s Edesa Biotech EDSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,348
Closed -$124K 3350
2021
Q2
$124K Hold
3,348
﹤0.01% 3215
2021
Q1
$127K Hold
3,348
﹤0.01% 3093
2020
Q4
$100K Buy
3,348
+1,116
+50% +$45.6K ﹤0.01% 2935
2020
Q3
$126K Buy
+2,232
New +$106K ﹤0.01% 2722

Other funds holding EDSA

Stifel Financial's EDSA Position: Q3 2021 in Review

Stifel Financial sold out of Edesa Biotech (EDSA) in Q3 2021, closing a stake of 3,348 shares — an estimated $124K sold.

Stifel Financial first reported a position in EDSA in Q3 2020 and held it in 4 quarters. The position peaked at $127K in Q1 2021. 22 funds tracked by Wall St. Rank hold EDSA as of Q3 2021.

  • Stifel Financial reported no remaining Edesa Biotech position as of Q3 2021 after selling out during the quarter.
  • Stifel Financial sold 3,348 Edesa Biotech shares in Q3 2021, an estimated $124K.
  • Stifel Financial first reported a position in Edesa Biotech in Q3 2020 and held it in 4 quarters.
  • Stifel Financial's Edesa Biotech position peaked at $127K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Edesa Biotech as of Q3 2021.

Based on Stifel Financial's 13F filing for Q3 2021, filed 15 Nov 2021.